NFKB1 and cancer: However, although the inhibition of NF-κB can potentially hinder the development of some types of cancer, including PDAC, there have been studies underscoring the fact that the role of NF-κB can be highly context- and cell-type-dependent and that the blocking of this pathway can result in opposing results [18,23,47].